0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Pneumococcal Vaccine Market Grows as Immunization and Preventive Healthcare Gain Focus" According to the latest report published by Data Bridge Market Research, the Pneumococcal Vaccine Market CAGR Value The global pneumococcal vaccine market size was valued at USD 9.28 billion in 2025 and is expected to reach USD 14.24 billion by 2033, at a CAGR of 5.5% during the forecast period Credible Pneumococcal Vaccine Market business...0 Комментарии 0 Поделились 549 Просмотры 0 предпросмотр
-
Pneumococcal Vaccine Market Growth Driven by Rising Immunization ProgramsThe Pneumococcal Vaccine Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Pneumococcal Vaccine Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and future potential to...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Pneumococcal Vaccine Market Opportunities Emerging from Increasing Healthcare Expenditure and Growing Focus on Infectious Disease PreventionAccording to a new report by Polaris Market Research, the global pneumococcal vaccine market was valued at USD 9.16 billion in 2025 and is projected to reach USD 14.57 billion by 2034, expanding at a CAGR of 5.30% over the forecast period. Growth is underpinned by rising incidence of pneumococcal disease across age groups, expanding government-backed immunization programs, and...0 Комментарии 0 Поделились 686 Просмотры 0 предпросмотр
-
US Pneumococcal Vaccine Market Trends: Expanding Focus on High-Risk Population ProtectionPolaris Market Research announces the release of its latest research report US pneumococcal vaccine Market. The newly published report captures all the key forces influencing market transformation. As industries evolve amid technological shifts, economic disruptions, and regulatory changes, the study outlines how the market is responding and where it is headed. Designed to serve decision-makers...0 Комментарии 0 Поделились 565 Просмотры 0 предпросмотр
-
Why Pneumococcal Vaccine Market Remains Important for Disease PreventionMarket Overview The pneumococcal vaccine market was valued at USD 9.16 billion in 2025 and is estimated at USD 9.61 billion in 2026. It is projected to reach USD 14.57 billion by 2034, expanding at a CAGR of 5.30% from 2026 to 2034. Pneumococcal vaccines are immunization products that protect against infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, bacteremia and...0 Комментарии 0 Поделились 320 Просмотры 0 предпросмотр
-
Asia Pacific Tops Regional Growth at 6.8% CAGR as North America Holds 40.9% of RevenuePneumococcal Vaccine Market size was valued at USD 9.16 billion in 2025 and is projected to grow from USD 9.61 billion in 2026 to USD 14.57 billion by 2034, exhibiting a CAGR of 5.30%, according to Polaris Market Research. Pneumococcal vaccines protect against infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, bacteremia and otitis media. They introduce safe...0 Комментарии 0 Поделились 28 Просмотры 0 предпросмотр